[Incidence of liver diseases in psoriatic patients with special reference to methotrexate therapy].
作者信息
Moldenhauer E, Dabels J, Diwok K, Leithäuser W, Nowotny P
出版信息
Dermatol Monatsschr. 1973 Mar;159(3):242-8.
PMID:4704945
Abstract
摘要
相似文献
1
[Incidence of liver diseases in psoriatic patients with special reference to methotrexate therapy].[银屑病患者肝脏疾病的发病率，特别提及甲氨蝶呤治疗]
Dermatol Monatsschr. 1973 Mar;159(3):242-8.
2
[Laboratory and oligobiopsy examination of the liver in patients with psoriasis treated with methotrexate (preliminary report)].[甲氨蝶呤治疗的银屑病患者肝脏的实验室及少组织活检检查（初步报告）]
Przegl Dermatol. 1974 Nov-Dec;61(6):803-7.
3
Hepatotoxicity of long-term methotrexate therapy for psoriasis.
Arch Intern Med. 1973 Sep;132(3):391-6.
4
Hepatotoxicity of methotrexate in the treatment of psoriasis.甲氨蝶呤治疗银屑病时的肝毒性。
Practitioner. 1973 Sep;211(263):324-8.
5
Liver injury associated with methotrexate therapy for psoriasis.
Mayo Clin Proc. 1973 Nov;48(11):787-92.
6
Pulmonary and hepatic complications of methotrexate therapy of psoriasis.甲氨蝶呤治疗银屑病的肺部和肝脏并发症。
JAMA. 1971 May 3;216(5):881-2.
7
Evaluation of possible chronic hepatotoxicity from methotrexate for psoriasis.
Arch Dermatol. 1970 Dec;102(6):613-8.
8
Hepatotoxicity of methotrexate in the treatment of psoriasis.
Arch Dermatol. 1971 Mar;103(3):250-61.
9
Effects of methotrexate on the liver in psoriasis.甲氨蝶呤对银屑病肝脏的影响。
J Invest Dermatol. 1974 Jun;62(6):597-602. doi: 10.1111/1523-1747.ep12679887.
10
Detection of hepatotoxicity associated with methotrexate therapy for psoriasis.
Arch Dermatol. 1989 Sep;125(9):1209-17.
Zotero 插件